Loading
P3 Health Partners Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Chicago Pacific Founders UGP III, LLC, was filed 13 Sept 2024.
Insider Decl.
100
Thresholds
n/a
Buy Volume
€12M
46 ops. · all time
Sell Volume
€712,944
3 ops. · all time
Who traded when
BuySaleHudson Vegas Investment SPV, LLC3 sales
Since the insiders bought
- -65.4%Entry US$24.95 · Close at T+365 US$8.63
- -82.3%Entry US$169.50 · Close at T+365 US$30.00
- -82.3%Entry US$169.50 · Close at T+365 US$30.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 25,380 of 26,248 companies
12.7
score / 100
Value18
Quality7
FCF yld-6.4%
Earn yld-10%
EV/EBITDA·
ROE-193%
Gross mgn·
Net mgn-10%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
US$3.81
Analyst consensus
2 analysts2.00/5
US$13.00Target US$18.00(+372%)US$23.00
Income statement
RevenueUS$1.5B
EBITDA-US$181.9M-12% margin
Net income-US$147.9M-6.6% margin
Valuation
Beta1.69
Balance sheet & cash
Market capUS$1.4B
Total debtUS$284.9M
Free Cash Flow-US$91.2M
Debt / Equity95%
Profitability & ownership
ROE-192.6%
ROA-13.4%
% insiders48.4%
% institutions8.3%
Last declaration on 14 August 2026
Declarations100 total
100,000 sharesClass A Common StockSEC:0001104659-26-097324:0
100,000 sharesClass V Common StockSEC:0001104659-26-097324:1
1,041 shares@ US$13.380.0010% mcap1.7% of flowClass A Common StockSEC:0001104659-26-094925:0
19,074 shares@ US$16.050.021% mcap37.2% of flowClass A Common StockSEC:0001104659-26-094925:1
29,885 shares@ US$16.860.035% mcap61.2% of flowClass A Common StockSEC:0001104659-26-094925:2
2,000 shares0Class A Common
StockSEC:0001492118-26-000001:0
2,000 shares0Class A Common
StockSEC:0001406618-26-000003:0
2,000 shares0Class A Common
StockSEC:0001232914-26-000002:0
2,000 shares0Class A Common
StockSEC:0001804153-26-000001:0
4,000 shares0Class A Common
StockSEC:0001334925-26-000001:0
2,000 shares0Class A Common
StockSEC:0001188827-26-000002:0
2,000 shares0Class A Common
StockSEC:0001832511-26-000003:0
2,000 shares0Class A Common
StockSEC:0001628280-25-039355:0
2,000 shares0Class A Common
StockSEC:0001628280-25-039350:0
2,000 shares0Class A Common
StockSEC:0001628280-25-039346:0
2,000 shares0Class A Common
StockSEC:0001628280-25-039358:0
4,000 shares0Class A Common
StockSEC:0001628280-25-039353:0
2,000 shares0Class A Common
StockSEC:0001628280-25-039352:0
2,000 shares0Class A Common
StockSEC:0001628280-25-039351:0
80,000 shares@ US$0.49940.5% of flowClass A Common StockSEC:0001213900-24-078697:1
Canonical exit: 12 Dec 2024 (T+90)
80,000 shares@ US$0.521.3% of flowClass A Common StockSEC:0001213900-24-078697:0
Canonical exit: 11 Dec 2024 (T+90)
80,000 shares@ US$0.51530.6% of flowClass A Common StockSEC:0001213900-24-078249:1
Canonical exit: 9 Dec 2024 (T+90)
80,000 shares@ US$0.55910.6% of flowClass A Common StockSEC:0001213900-24-078249:2
Canonical exit: 10 Dec 2024 (T+90)
80,000 shares@ US$0.53341.3% of flowClass A Common StockSEC:0001213900-24-078249:0
Canonical exit: 8 Dec 2024 (T+90)
80,000 shares@ US$0.49120.5% of flowClass A Common StockSEC:0001213900-24-077502:1
Canonical exit: 4 Dec 2024 (T+90)
25 of 100 declarations
About P3 Health Partners Inc.
On April 6, 2023, Chicago Pacific Founders UGP, LLC reported a EUR 5,120,966 purchase at P3 Health Partners Inc., most of the 46 purchases in the record, which total EUR 12.2 million (median EUR 176,437), 42 of them with an amount. Chicago Pacific Founders UGP III, LLC, of similar name, signs 37 filings, all purchases, including EUR 388,159 on May 23, 2023 and EUR 335,422 on May 25, 2023. From May 12, 2023 to June 1, 2023, 3 filers bought for EUR 4,072,950.
The 3 sales, which leave purchases at 94% of open-market trades, all belong to Hudson Vegas Investment SPV, LLC, a holder of more than 10%, on August 10, 2026: EUR 435,991, EUR 264,901 and EUR 12,052, for EUR 712,944 in total.
Read moreShow less
This US healthcare company, valued at USD 1.4 billion, has 100 filings from 20 filers, including 41 grants and 10 of another kind. The annual volume is 18 in 2021, 38 in 2023 and 12 in 2026. The last twelve months hold 12, of which 3 sales and no purchase. Filings come out a median of 2 days after the trade, and filers hold 48.4% of the capital. Sherif Abdou (Chief Executive Officer), Amir Bacchus (Chief Medical Officer) and Gregory N. Kazarian (Director) sign 6 filings each.
